A world without global intellectual property would be one of constant
electronic warfare. State-backed hacking, such as China apparently
tried with Moderna this week, would be a constant threat. Nor would
companies enjoy a comfortable relationship with their own governments,
who would see them less as engines of growth and more as storehouses
of national wealth.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pricing-covid-19-vaccines-too-high-could-backfire-on-big-pharmaceutical-companies/articleshow/77325474.cms
Sunday, 2 August 2020
Govt Food Safety Officer Recruitment – Biotech / Food Tech / Microbiology Apply
Govt Food Safety Officer Recruitment – Biotech / Food Tech /
Microbiology Apply Govt Food Safety Officer Recruitment – Biotech /
Food Tech / Microbiology Apply. MSc candidates with a degree in
Biotechnology, Food Technology and Microbiology are encouraged to
apply for a food safety officer vacancy. Interested applicants can
check out all of the […]
The post Govt Food Safety Officer Recruitment – Biotech / Food Tech /
Microbiology Apply appeared first on BioTecNika .
https://www.biotecnika.org/2020/08/govt-food-safety-officer-recruitment-biotech-food-tech-microbio/
Biotech Jobs,Featured,Food Technology Jobs,Government
Jobs,Jobs,M.Sc,Microbiology Jobs
Microbiology Apply Govt Food Safety Officer Recruitment – Biotech /
Food Tech / Microbiology Apply. MSc candidates with a degree in
Biotechnology, Food Technology and Microbiology are encouraged to
apply for a food safety officer vacancy. Interested applicants can
check out all of the […]
The post Govt Food Safety Officer Recruitment – Biotech / Food Tech /
Microbiology Apply appeared first on BioTecNika .
https://www.biotecnika.org/2020/08/govt-food-safety-officer-recruitment-biotech-food-tech-microbio/
Biotech Jobs,Featured,Food Technology Jobs,Government
Jobs,Jobs,M.Sc,Microbiology Jobs
Biotecnika Times – Newsletter 03.08.2020 – AIIMS Scientist Job, CSIR-NCL Recruitment
Biotecnika Times – AIIMS Scientist Job, CSIR-NCL Recruitment CSIR-NCL
microRNA-based Project Recruitment – Rs. 42,000 pm Salary NCL PhD Job
Opening – Research Associate With Rs. 42,000 pm Pay. NCL Pune is
hiring PhD Biochemistry /Biotechnology/ Botany/ Microbiology/Zoology/
Life Sciences candidates for a project post. AIIMS Scientist
(Embryologist) Post With Rs. 58,000 pm Salary AIIMS […]
The post Biotecnika Times – Newsletter 03.08.2020 – AIIMS Scientist
Job, CSIR-NCL Recruitment appeared first on BioTecNika .
https://www.biotecnika.org/2020/08/biotecnika-times-newsletter-03-08-2020-aiims-scientist-job-csir-ncl-recruitment/
BioTecNika Times
microRNA-based Project Recruitment – Rs. 42,000 pm Salary NCL PhD Job
Opening – Research Associate With Rs. 42,000 pm Pay. NCL Pune is
hiring PhD Biochemistry /Biotechnology/ Botany/ Microbiology/Zoology/
Life Sciences candidates for a project post. AIIMS Scientist
(Embryologist) Post With Rs. 58,000 pm Salary AIIMS […]
The post Biotecnika Times – Newsletter 03.08.2020 – AIIMS Scientist
Job, CSIR-NCL Recruitment appeared first on BioTecNika .
https://www.biotecnika.org/2020/08/biotecnika-times-newsletter-03-08-2020-aiims-scientist-job-csir-ncl-recruitment/
BioTecNika Times
BCG shots could slow down Covid-19 spread in first thirty days, says study
The paper published in Science Advances, a peer-reviewed medical
journal brought out by the American Association for the Advancement of
Science, said that countries with mandatory Bacillus Calmette-Guérin
(BCG) vaccination showed "slower infection and death rates" during the
first 30 days of the Covid-19 outbreak in their country.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bcg-shots-could-slow-down-covid-19-spread-in-first-thirty-days-says-study/articleshow/77313332.cms
journal brought out by the American Association for the Advancement of
Science, said that countries with mandatory Bacillus Calmette-Guérin
(BCG) vaccination showed "slower infection and death rates" during the
first 30 days of the Covid-19 outbreak in their country.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bcg-shots-could-slow-down-covid-19-spread-in-first-thirty-days-says-study/articleshow/77313332.cms
Lupin recalls 35,928 bottles of generic antibiotic drug 'Cefdinir' in the US market
As per the latest Enforcement Report of the US Food and Drug
Administration (USFDA), the Mumbai-based company is recalling Cefdinir
for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-35928-bottles-of-generic-antibiotic-drug-cefdinir-in-the-us-market/articleshow/77313074.cms
Administration (USFDA), the Mumbai-based company is recalling Cefdinir
for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-35928-bottles-of-generic-antibiotic-drug-cefdinir-in-the-us-market/articleshow/77313074.cms
Saturday, 1 August 2020
US generics business to continue its growth momentum: Pharma firm Cadila Healthcare
According to the Cadila Healthcare's annual report for fiscal year
2019-20, the company is planning to introduce additional "topical,
transdermal and injectable products" in coming years. The US was the
largest contributor to the consolidated revenues of the company with
45 per cent share, it said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-generics-business-to-continue-its-growth-momentum-pharma-firm-cadila-healthcare/articleshow/77312223.cms
2019-20, the company is planning to introduce additional "topical,
transdermal and injectable products" in coming years. The US was the
largest contributor to the consolidated revenues of the company with
45 per cent share, it said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-generics-business-to-continue-its-growth-momentum-pharma-firm-cadila-healthcare/articleshow/77312223.cms
Zydus Cadila gets tentative nod from USFDA to market Parkinson's disease drug
The company has received tentative approval from the United States
Food and Drug Administration (USFDA) to market the capsules in the
strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and
61.25 mg/245 mg, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-tentative-nod-from-usfda-to-market-parkinsons-disease-drug/articleshow/77299625.cms
Food and Drug Administration (USFDA) to market the capsules in the
strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and
61.25 mg/245 mg, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-tentative-nod-from-usfda-to-market-parkinsons-disease-drug/articleshow/77299625.cms
Subscribe to:
Posts (Atom)